Evidence map›Paper›PMID 40170614›Full record

ArticleBJPsych open2025

Effects of vaping on physical and mental health in at-risk populations (VAPE): mixed-methods study of motivations for and perspectives on vaping in patients with opioid use disorder.

Alessia D'Elia, Balpreet Panesar, Nitika Sanger, Laura O'Neill, Tea Rosic, Leonora Regenstreif, Kevin Park, Claire de Oliveira, David C Marsh, Luciano Minuzzi and 2 more

Abstract read
In one paragraph

Article in BJPsych open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessia D'EliaNeuroscience Graduate Program, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0002-6512-4704
Balpreet PanesarNeuroscience Graduate Program, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0002-5492-3615
Nitika SangerDepartment of Psychiatry and Behavioural Neurosciences, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0002-5883-1873
Laura O'NeillDepartment of Psychiatry and Behavioural Neurosciences, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Tea RosicChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0001-7406-4056
Leonora RegenstreifAssistant Clinical Professor, Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0001-7161-1712
Kevin ParkIndependent Researcher, Toronto, Ontario, Canada.
Claire de OliveiraInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-3961-6008
David C MarshNorthern Ontario School of Medicine, Sudbury, Ontario, Canada.ORCID https://orcid.org/0000-0002-8769-1785
Luciano MinuzziDepartment of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0001-7532-1851
Lehana ThabaneDepartment of Health Research, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0003-0355-9734
Zainab SamaanDepartment of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0002-5974-9361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaping is increasing in popularity. Vape products are offered in a wide variety and promise to reduce harms associated with cigarette smoking, among other claims. The motivations for vaping in patients with substance use disorder are largely unknown.

aimsTo describe perceptions and motivations regarding vaping among patients with opioid use disorder (OUD) who vape.

methodA convergent mixed-methods study design was used, and individual, semi-structured interviews were conducted with 41 individuals with OUD who were receiving medication for OUD and also vaped. An inductive data-driven approach was employed to characterise perspectives on vaping.

resultsThe mean ages at which participants had been introduced to vaping and initiated regular vaping were 33.95 years (s.d. 12.70) and 34.85 years (s.d. 12.38), respectively. Daily vaping (85%) of nicotine, flavoured nicotine or cannabis was common, with 27% reporting vaping both nicotine and cannabis. Qualitative analysis identified 14 themes describing motivations for vaping, including viewing vaping as a smoking cessation tool, convenience and popularity among youth.

conclusionsMixed-methods findings indicated that patients with OUD who vape perceived vaping to be healthier, cleaner and more convenient than cigarette and cannabis smoking, without appreciating the health risks. The perspectives reflected the importance of health education, guidelines and screening tools for vaping and could provide direction for healthcare providers and future vaping cessation programmes.

Indexed as

Cannabisopioid disordersperceptionqualitative researchVAPE

Identifiers

PMID40170614
PMCPMC12052573

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.